Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger(Sidney Kimmel Comprehensive Cancer Center), Douglas E. Wood(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dara L. Aisner(University of Colorado Cancer Center), Wallace Akerley(University of Utah), Jessica R. Bauman(Fox Chase Cancer Center), Ankit Bharat(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Débora S. Bruno(Cleveland Clinic), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Lucian R. Chirieac(Dana-Farber Brigham Cancer Center), Thomas A. D’Amico(Cancer Institute (WIA)), Malcolm M. DeCamp(University of Wisconsin Carbone Cancer Center), Thomas J. Dilling(Moffitt Cancer Center), Jonathan E. Dowell(Southwestern Medical Center), Scott Gettinger(Smilow Cancer Hospital), Travis E. Grotz(Cancer Clinic), Matthew A. Gubens(UCSF Helen Diller Family Comprehensive Cancer Center), Aparna Hegde(University of Colorado Cancer Center), Rudy P. Lackner(Susan Thompson Buffett Foundation), Michael Lanuti(Massachusetts General Hospital), Jules Lin(University of Michigan), Billy W. Loo(Cancer Institute (WIA)), Christine M. Lovly(Breast Cancer Research Foundation), Fabien Maldonado(Breast Cancer Research Foundation), Erminia Massarelli(City Of Hope National Medical Center), Daniel Morgensztern(Barnes-Jewish Hospital), Thomas Ng(University of Tennessee Health Science Center), Gregory A. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jose M. Pacheco(University of Colorado Cancer Center), Sandip Pravin Patel(Moore College of Art and Design), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Jonathan W. Riess(Comprehensive Blood & Cancer Center), Steven E. Schild(Cancer Clinic), Theresa A. Shapiro(Sidney Kimmel Comprehensive Cancer Center), Aditi P. Singh(UPMC Hillman Cancer Center), James Stevenson(Cleveland Clinic), Alda L. Tam(The University of Texas MD Anderson Cancer Center), Tawee Tanvetyanon(Moffitt Cancer Center), Jane Yanagawa(Comprehensive Blood & Cancer Center), Stephen C. Yang(Sidney Kimmel Comprehensive Cancer Center), Edwin Yau, Kristina M. Gregory(National Comprehensive Cancer Network), Miranda Hughes(National Comprehensive Cancer Network)
Cited by 1,411
Abstract
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
Related Papers
No related papers found
Powered by citation graph analysis